Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain.
Adiposity
Body fat distribution
Body mass index
Body size
Cancer
Electronic health records
Obesity
Waist circumference
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
14 01 2021
14 01 2021
Historique:
received:
09
09
2020
accepted:
01
12
2020
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
24
6
2021
Statut:
epublish
Résumé
A high body mass index (BMI) has been associated with increased risk of several cancers; however, whether BMI is related to a larger number of cancers than currently recognized is unclear. Moreover, whether waist circumference (WC) is more strongly associated with specific cancers than BMI is not well established. We aimed to investigate the associations between BMI and 26 cancers accounting for non-linearity and residual confounding by smoking status as well as to compare cancer risk estimates between BMI and WC. Prospective cohort study with population-based electronic health records from Catalonia, Spain. We included 3,658,417 adults aged ≥ 18 years and free of cancer at baseline between 2006 and 2017. Our main outcome measures were cause-specific hazard ratios (HRs) with 99% confidence intervals (CIs) for incident cancer at 26 anatomical sites. After a median follow-up time of 8.3 years, 202,837 participants were diagnosed with cancer. A higher BMI was positively associated with risk of nine cancers (corpus uteri, kidney, gallbladder, thyroid, colorectal, breast post-menopausal, multiple myeloma, leukemia, non-Hodgkin lymphoma) and was positively associated with three additional cancers among never smokers (head and neck, brain and central nervous system, Hodgkin lymphoma). The respective HRs (per 5 kg/m In this large Southern European study, a higher BMI was associated with increased risk of twelve cancers, including four hematological and head and neck (only among never smokers) cancers. Furthermore, BMI and WC showed comparable estimates of cancer risk associated with adiposity.
Sections du résumé
BACKGROUND
A high body mass index (BMI) has been associated with increased risk of several cancers; however, whether BMI is related to a larger number of cancers than currently recognized is unclear. Moreover, whether waist circumference (WC) is more strongly associated with specific cancers than BMI is not well established. We aimed to investigate the associations between BMI and 26 cancers accounting for non-linearity and residual confounding by smoking status as well as to compare cancer risk estimates between BMI and WC.
METHODS
Prospective cohort study with population-based electronic health records from Catalonia, Spain. We included 3,658,417 adults aged ≥ 18 years and free of cancer at baseline between 2006 and 2017. Our main outcome measures were cause-specific hazard ratios (HRs) with 99% confidence intervals (CIs) for incident cancer at 26 anatomical sites.
RESULTS
After a median follow-up time of 8.3 years, 202,837 participants were diagnosed with cancer. A higher BMI was positively associated with risk of nine cancers (corpus uteri, kidney, gallbladder, thyroid, colorectal, breast post-menopausal, multiple myeloma, leukemia, non-Hodgkin lymphoma) and was positively associated with three additional cancers among never smokers (head and neck, brain and central nervous system, Hodgkin lymphoma). The respective HRs (per 5 kg/m
CONCLUSIONS
In this large Southern European study, a higher BMI was associated with increased risk of twelve cancers, including four hematological and head and neck (only among never smokers) cancers. Furthermore, BMI and WC showed comparable estimates of cancer risk associated with adiposity.
Identifiants
pubmed: 33441148
doi: 10.1186/s12916-020-01877-3
pii: 10.1186/s12916-020-01877-3
pmc: PMC7807518
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10Subventions
Organisme : Wereld Kanker Onderzoek Fonds
ID : 2017/1630
Organisme : Department of Health of the Generalitat de Catalunya
ID : SLT002/16/00308
Références
Int J Cancer. 2008 Mar 15;122(6):1418-21
pubmed: 18027857
Lancet. 2014 Aug 30;384(9945):755-65
pubmed: 25129328
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
Nat Rev Cancer. 2004 Aug;4(8):579-91
pubmed: 15286738
Med Clin (Barc). 2012 May 19;138(14):617-21
pubmed: 22444996
Br J Cancer. 2019 Apr;120(7):768-770
pubmed: 30808991
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):597-606
pubmed: 28314823
Ann Oncol. 2012 Jul;23(7):1665-71
pubmed: 22228452
Eur J Nutr. 2018 Aug;57(5):1701-1720
pubmed: 29080978
Int J Cancer. 2008 May 1;122(9):2062-70
pubmed: 18167059
J Clin Oncol. 2016 Sep 20;34(27):3237-9
pubmed: 27458311
Ann Oncol. 2015 Aug;26(8):1635-48
pubmed: 25791635
Nat Commun. 2019 Jan 22;10(1):383
pubmed: 30670692
Cancer. 2015 Oct 15;121(20):3700-8
pubmed: 26193782
Cancer Epidemiol. 2018 Oct;56:31-37
pubmed: 30029068
Gac Sanit. 2008 May-Jun;22(3):179-87
pubmed: 18579042
Int J Cancer. 2013 Mar 1;132(5):1162-9
pubmed: 22777722
Eur J Cancer. 2011 Jul;47(11):1606-15
pubmed: 21354783
Endocrinol Diabetes Nutr. 2017 Mar;64 Suppl 1:15-22
pubmed: 27543006
Ann Oncol. 2019 Apr 1;30(4):528-541
pubmed: 30753270
Am J Epidemiol. 2010 Mar 1;171(5):624-32
pubmed: 20106935
Eur J Cancer. 2012 Sep;48(14):2137-45
pubmed: 22446023
Epidemiology. 1999 Jan;10(1):37-48
pubmed: 9888278
Br J Cancer. 2017 May 23;116(11):1486-1497
pubmed: 28441380
Obes Rev. 2015 Dec;16(12):1042-54
pubmed: 26365757
J Natl Cancer Inst. 2006 Jul 5;98(13):920-31
pubmed: 16818856
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3119-30
pubmed: 21030602
Cancer Causes Control. 2016 Mar;27(3):291-300
pubmed: 26759333
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Eur J Cancer. 2011 Nov;47(16):2422-30
pubmed: 21733676
Clin Epidemiol. 2017 Mar 15;9:157-166
pubmed: 28352203
Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1395-408
pubmed: 23697611
Inform Prim Care. 2011;19(3):135-45
pubmed: 22688222
BMJ. 2007 Dec 1;335(7630):1134
pubmed: 17986716
Int J Epidemiol. 2015 Apr;44(2):673-81
pubmed: 26050257
Br J Cancer. 2019 Mar;120(6):575-576
pubmed: 30778142
Clin Epidemiol. 2019 Dec 03;11:1015-1024
pubmed: 31819655
Sci Rep. 2015 Nov 19;5:16938
pubmed: 26582414